Archer Aviation Just Slapped a Countersuit on Rival Joby. Here's How It Could Affect the Air Taxi Rivals' Stock.

The U.S. Department of Transportation selected Joby and Archer for multiple Advanced Air Mobility/eIPP projects, sending both stocks higher; recall that in November Archer slid ~8% and Joby fell ~4.6% after Joby sued over alleged corporate espionage before both rebounded and rose double-digits in early December. Joby alleges a former employee stole confidential filings; Archer's countersuit accuses Joby of using a Chinese subsidiary to source parts misclassified to avoid tariffs and claims secret ties to the Chinese government. Market reaction has been muted and the article concludes the legal fight is unlikely to move shares materially absent irrefutable evidence — FAA commercial approval for eVTOLs is the more important near-term catalyst.

Analysis

The market is treating litigation as transient noise while anchoring value to certification and commercial ramp timelines; that gap creates predictable dispersion between headline-driven intraday moves and fundamental progress over 12–36 months. If regulators pivot to supply‑chain audits or tariff reviews, expect liquidity and procurement cycles to reprice quickly: a documented indemnity or back‑tax exposure can force repricing of equity by 20–40% within weeks as customers and insurers push renegotiations.

Second‑order winners are firms that can credibly supply certified, on‑shore or allied‑country subsystems (actuators, flight‑control electronics, composite fuselage sections) because buyers will pay a premium to de‑risk import classification and regulatory scrutiny; conversely, small OEMs reliant on single-source offshore vendors are exposed to outsized contract and certification delays. Volatility is the near‑term catalyst (days–months) while FAA/DoT milestones remain the long lead catalyst (12–36 months); use options to extract value from IV swings around government and regulatory filings rather than directional bets on headline noise.

The consensus underestimates how quickly procurement and insurance markets react to credibility shocks: a supply‑chain allegation can trigger supplier audits, escrow demands, and higher warranty reserves that compress net cash flow conversion by 100–300bps annually until resolved. That mechanism means litigation can be a cash‑flow event even if it fails in court — treat legal developments as potential liquidity and certification risk multipliers, not merely PR events.

Key Decisions for Investors

• Directional pair: Long JOBY (JOBY) vs short Archer (ACHR) 1:1 for a 6–12 month horizon. Size at 2–5% portfolio exposure to capture re‑rating if certification progress continues; stop‑loss if pair diverges >35% to limit tail risk from idiosyncratic regulatory findings.
• Asymmetric options: Buy 12‑month JOBY LEAP calls (near‑ATM) sized 1–3% of portfolio for 2x–4x upside if FAA milestones hit within 12–24 months; limited downside = premium paid. This expresses secular commercialization upside while capping loss if litigation noise persists.
• Near‑term event hedge: Purchase a 1–3 month put spread on ACHR (ATM to 10% OTM) sized at 0.5–1% of portfolio to protect against a negative regulatory discovery or cash‑flow shock that could compress shares by 20–40%. Cost is limited; payout mitigates immediate downside risk from new filings or audits.
• Volatility trade: Sell short‑dated straddles/strangles around predictable non‑technical announcements (program award windows) on the more liquid name, financing for theta into IV spikes. Keep position small, hedge directionally with underlying to avoid large gamma exposure; exit post‑announcement to capture IV collapse.